TRANSCUTANEOUS ELECTRICAL ACUPOINT STIMULATION FOR CISPLATIN- CHEMOTHERAPY INDUCED NAUSEA AND VOMITING

Inclusion Criteria: * Male and female patients who their ages between 40 and 60. * All patients diagnosed with cancer and planned to receive TACE treatment with cisplatin (60 mg) as the main drug. The chemotherapy regimen will not include steroids. * Karnofsky's score ≥60. * All patients will receive the same antiemetic drug. * None of them receiving other physical therapy modalities to treat nausea and vomiting. * The skin of acupoint site receiving electrical acupoint stimulation must be intact and without visible evidence of injury * All patient can tolerate mild discomfort following electrical stimulation. * All patients enrolled in the study will have their informed consent. Exclusion Criteria: * Combined use of other venous chemotherapy within 5 days after Transarterial Chemoembolization * Other confounding factors that may cause nausea and vomiting (such as intestinal obstruction, anorexia, and so on) * Having vomited or used 5 HT3 receptor antagonists or other antiemetics within 24 hours before Transarterial Chemoembolization . * Receiving concurrent radiotherapy * Severe uncontrolled complications and unstable metastases * Installing pacemaker, Pregnancy. * History of convulsions or seizure disorder. * Cognitive dysfunction, unable to finish Scale * Transcutaneous electrical acupoint stimulation treatment within the past year regardless of indication.